Related Experiment Video
Updated: Mar 14, 2026

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
CEACAM1: Expression and Role in Melanocyte Transformation
Gabriela Turcu1, Roxana Ioana Nedelcu2, Daniela Adriana Ion2
1Colentina Clinical Hospital, 1st Dermatology Department, "Carol Davila" University of Medicine and Pharmacy, 020125 Bucharest, Romania.
Abstract:
Metastases represent the main cause of death in melanoma patients. Despite the current optimized targeted therapy or immune checkpoint inhibitors the treatment of metastatic melanoma is unsatisfactory. Because of the poor prognosis of advanced melanoma there is an urgent need to identify new biomarkers to differentiate melanoma cells from normal melanocytes, to stratify patients according to their risk, and to identify subgroups of patients that require close follow-up or more aggressive therapy. Furthermore, melanoma progression has been associated with the dysregulation of cell adhesion molecules. We have reviewed the literature and have discussed the important role of the expression of the carcinoembryonic antigen cell adhesion molecule 1 (CEACAM1) in the development of melanoma. Thus, novel insights into CEACAM1 may lead to promising strategies in melanoma treatment, in monitoring melanoma patients, in assessing the response to immunotherapy, and in completing the standard immunohistochemical panel used in melanoma examination.
Insights
Metastatic melanoma remains a deadly disease. Carcinoembryonic antigen cell adhesion molecule 1 (CEACAM1) shows promise as a biomarker for melanoma diagnosis, risk stratification, and treatment monitoring.
Area of Science:
- Oncology
- Cell Biology
- Immunology
Background:
- Metastatic melanoma is a leading cause of cancer death, with current treatments often proving insufficient.
- Advanced melanoma necessitates novel biomarkers for accurate patient stratification and risk assessment.
- Melanoma progression is linked to altered expression of cell adhesion molecules.
Purpose of the Study:
- To review the literature on the role of carcinoembryonic antigen cell adhesion molecule 1 (CEACAM1) in melanoma development.
- To explore CEACAM1 as a potential biomarker for melanoma diagnosis and patient management.
- To discuss the implications of CEACAM1 expression for melanoma treatment and monitoring.
Main Methods:
- Literature review focusing on CEACAM1 expression in melanoma.
- Analysis of the association between CEACAM1 and melanoma progression.
- Discussion of CEACAM1's potential clinical applications.
Main Results:
- CEACAM1 expression is significantly implicated in melanoma development.
- Dysregulation of cell adhesion molecules, including CEACAM1, is observed during melanoma progression.
- CEACAM1 offers potential as a biomarker for differentiating melanoma cells and normal melanocytes.
Conclusions:
- CEACAM1 represents a promising target for novel melanoma treatment strategies.
- Understanding CEACAM1 expression can aid in monitoring melanoma patients and assessing immunotherapy response.
- CEACAM1 may enhance standard immunohistochemical panels used in melanoma diagnostics.
Related Concept Videos
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
MAPK Signaling Cascades
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Pigmentation
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
Cell Specific Gene Expression
Induced Pluripotent Stem Cells
Somatic...

